La inflamación y su papel en el desarrollo de cáncer gástrico
DOI:
https://doi.org/10.51481/amc.v51i2.224Palabras clave:
Inflamación, citoquinas, interleuquinas, Helicobacter pylori, cáncer gástricoResumen
La infección por Helicobacter pylori produce, en algunos pacientes, inflamación crónica en el estómago, gastritis atrófica y cáncer gástrico. Los mecanismos moleculares que conducen de la infección a la inflamación crónica y al cáncer son desconocidos. La magnitud y el proceso de la inflamación dependen del tipo de cepa de H. pylori y de la respuesta del hospedero ante la infección. Esta respuesta inflamatoria está regulada por citoquinas, algunas de las cuales han sido asociadas con cambios en la secreción de ácido en el estómago y con el riesgo de desarrollar cáncer gástrico y varias lesiones gástricas precancerosas. Sin embargo, la relación entre citoquinas y cáncer gástrico no es del todo clara. Esta revisión se enfoca en los procesos inflamatorios asociados con el desarrollo del cáncer gástrico.
Descargas
Citas
De Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6:24-37.
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001;357:539-545.
Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000. 248;171-183.
Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006; 19:449-490.
Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37Suppl 8:S4-66.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M. et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
Sierra R, Parkin DM, Leiva GM. Cancer in Costa Rica. Cancer Res 1989; 49:717-724.
Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem
E. Gastric cancer. Crit Rev Oncol Hematol 2005; 54:209-241.
Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006; 20:651-674.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52:6735-6740.
McColl KE. Cancer of the gastric cardia. Best Pract Res Clin Gastroenterol 2006; 20:687-696.
Stemmermann GN, Fenoglio-Preiser C. Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precursors to a preventable cancer. Pathology 2002; 34:494-503.
Suzuki H, Hibi T, and Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007; 42:1-15.
Prinz C, Schwendy S, and P. Voland P. H. pylori and gastric cancer: shifting the global burden. World J Gastroenterol 2006; 12:5458-5464.
Smith MG, Hold GL, Tahara E, El-Omar E. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12:2979-2990.
Wang HT, Li ZH, Yuan JP, Zhao W, Shi XD, Tong SQ, et al. Effect of Helicobacter pylori VacA on gene expression of gastric cancer cells. World J Gastroenterol 2005; 11:109-113.
Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4:688-694.
Naumann M. Pathogenicity island-dependent effects of Helicobacter pylori on intracellular signal transduction in epithelial cells. Int J Med Microbiol 2005; 295:335-341.
Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 2003; 56:287-291.
Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001; 36:128135.
El-Omar EM, Chow WH, Rabkin CS. Gastric cancer and H. pylori: Host genetics open the way. Gastroenterology 2001; 121:1002-1004.
Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter 2001; 6:116-124.
Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: Insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterolory 2007; 133:288-308.
Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-2147.
Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994; 19:382-384.
El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402. Corrección en: Nature 2001; 412:99.
Furuta T, El-Omar E, Xiao F, Shirai N, Takashima M, Sugimurra H, et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92-105.
Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121:823-829.
Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94:1680-1687.
Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, Voland P, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003; 188:272281.
Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42:227-234.
Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E, et al. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001; 48: 765-773.
Idriss HT, Naismith JH, TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 2000; 50:184195.
Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 1995; 43:227-235.
Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factoralpha in disease states and inflammation. Crit Care Med 1993; 21: S447-463.
Higuchi T, Seki N, Kamisono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5’-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51:605612.
Skoo, T, van`t Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factoralpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8:1443-1449.
Hou L, El-Omar E, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007; 28:118-123.
Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125:364-371.
El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124:1193-1201.
Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005; 29:141-52.
Russo F, Jirillo E, Clemente C, Messa C, Chiloiro M, Riezzo G, et al. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol Immunotoxicol, 2001; 23:13-24.
Genta RM. The immunobiology of Helicobacter pylori gastritis. Semin Gastrointest Dis 1997; 8:2-11.
Roebuck KA. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 1999; 19:429-438.
Matsushima K, Baldwin ET, Mukaida N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol 1992; 51:236-265.
Eck M, Schmauβer B, Scheller K, Brändlein S, Müller-Hermelink HK. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 2003; 134:508-515.
Koch AE, Polverini PJ, Kundel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258:1798-1801.
Strieter RM, Kundel SL, Elner VM, Matonyi CL, Koch AE, Polverini PJ, et al. Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 1992; 141:1279-1284.
Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hirooka Y, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005; 14:2487-2493.
Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005; 54:330-335.
Lee WP, Tai DI, Lan KH, Li AFY, Hsu HC, Lin EJ, et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 2005; 11:6431-6441.
Garza-González E, Bosques-Padilla FJ, Mendoza-Ibarra SI, FloresGutierrez JP, Maldonado-Garza HJ, Pérez-Pérez G. Assesment of the toll-like receptor 4 Asp299Gly, Tyr399Ile and interleukin-8-251 polymorphisms in the risk for development of distal gastric cancer.
BMC cancer 2007; 7:70-75.
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683765.
Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo, et al. Polymorphic haplotypes of the interleukin-10 5’ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42:1101-1108.
Eskdale J, Kube D, Tesch H, Gallagher G, et al. Mapping of the human IL10 gene and further characterization of the 5’ flanking sequence. Immunogenetics 1997; 46:120-128.
Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26:631-636.
Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003; 104:617-623.
Navaglia F, Basso D, Zambon CF, Pozano E, Caenazzo L, Gallo N, et al. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H. pylori infected individuals. J Med Genet 2005; 42:503-510.
Seno H, Sato K, Tsuji S, Shiratsuchi T, Harada Y, Hamajima N, et al. Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J Gastroenterol Hepatol 2007; 22:729-737.
Serrano C, Diaz MI, Valdivia A, Godoy A, Peña A, Rollan A, et al. Relationship between Helicobacter pylori virulence factors and regulatory cytokines as predictors of clinical outcome. Microbes Infect 2007; 9:428-434.
Togawa S, Joh T, Itoh M, Katsuda N, Ito H, Matsuo K, et al. Interleukin2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter 2005; 10:172-178.
Kamangar F, Cheng C, Abnet CC, Rabkin CS. Interleukin-1B polymorphisms and gastric cancer risk--a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1920-1928.
Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001; 36:696-699.
Wang P, Xia HHX, Zhang JY, Dai LP, Xu XQ, Wang KJ. Association of interleukin-1 gene polymorphisms with gastric cancer: a metaanalysis. Int J Cancer 2007; 120:552-562.
Camargo MC, Mera R, Correa P, Peek RM, Fontham ETH, Goodman KJ, et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1674-1687.
Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 2003; 52:1684-1689.
Sicinschi LA, Lopez-Carrillo L, Camargo MC, Correa P, Sierra RA, Henry RR, et al. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int J Cancer 2006; 118:649-657.
Lobo Gatti L, Rodríguez Burbano R, Pimentel de Assumpcao P, Cardoso Smith M, Marques Payao SL. Interleukin-1beta polymorphisms, Helicobacter pylori infection in individuals from Northern Brazil with gastric adenocarcinoma. Clin Exp Med 2004; 4:93-98.
Kato I, Canzian F, Franceschi S, Plummer M, van Doorn LY, Lu Y, et al. Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela. Cancer Causes Control 2006; 17:1183-1191.
Alpizar-Alpizar W, Pérez-Pérez GI, Une C, Cuenca P, Sierra R. Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med 2005; 5:169-176.
Zhang WH, Wang XL, Zhou J, An LZ, Xie XD. Association of interleukin-1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. Cytokine 2005; 30:378-381.
Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123:1793-1803.
Rad R, Dosumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53:1082-1089.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2009 Acta Médica Costarricense
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
